» Articles » PMID: 4257494

The Hurler Corrective Factor. Purification and Some Properties

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 1971 Dec 25
PMID 4257494
Citations 28
Authors
Affiliations
Soon will be listed here.
Citing Articles

Polymer-based drug delivery systems under investigation for enzyme replacement and other therapies of lysosomal storage disorders.

Placci M, Giannotti M, Muro S Adv Drug Deliv Rev. 2023; 197:114683.

PMID: 36657645 PMC: 10629597. DOI: 10.1016/j.addr.2022.114683.


Therapeutic Approaches in Lysosomal Storage Diseases.

Fernandez-Pereira C, San Millan-Tejado B, Gallardo-Gomez M, Perez-Marquez T, Alves-Villar M, Melcon-Crespo C Biomolecules. 2021; 11(12).

PMID: 34944420 PMC: 8698519. DOI: 10.3390/biom11121775.


Enzyme Replacement Therapy for Mucopolysaccharidosis IIID using Recombinant Human α--Acetylglucosamine-6-Sulfatase in Neonatal Mice.

Wang F, Moen D, Sauni C, Kan S, Li S, Le S Mol Pharm. 2020; 18(1):214-227.

PMID: 33320673 PMC: 8362844. DOI: 10.1021/acs.molpharmaceut.0c00831.


Substrate Deprivation Therapy to Reduce Glycosaminoglycan Synthesis Improves Aspects of Neurological and Skeletal Pathology in MPS I Mice.

Derrick-Roberts A, Jackson M, Pyragius C, Byers S Diseases. 2017; 5(1).

PMID: 28933358 PMC: 5456338. DOI: 10.3390/diseases5010005.


A review of gene therapy in canine and feline models of lysosomal storage disorders.

Bradbury A, Gurda B, Casal M, Ponder K, Vite C, Haskins M Hum Gene Ther Clin Dev. 2015; 26(1):27-37.

PMID: 25671613 PMC: 4516914. DOI: 10.1089/humc.2015.002.